Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG39346

DNAJC7 Knockout NCI-H1299 Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Lung

  • Disease:

    Carcinoma

The DNAJC7 Knockout NCI-H1299 Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout population in the TP53-null NCI-H1299 lung adenocarcinoma line. DNAJC7 encodes a co-chaperone that regulates HSP70 ATPase activity, interacting with HSPA1A/HSPA8, BAG co-chaperones, and STUB1/CHIP to control protein folding. Knockout disrupts proteostasis, leading to protein aggregation. These cells model chaperone-mediated stress responses and proteostasis in cancer, enabling assays such as western blotting for HSP70 clients, proteasome activity measurements, stress viability tests, and aggregate imaging.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    NCI-H1299

    Sex of Donor

    Male

    Age

    43 years

    Gene Name

    DNAJC7

    Gene Identifier

    NCBI Gene ID 7266

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    RPMI 1640

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The DNAJC7 Knockout NCI-H1299 Polyclonal Cells product provides a CRISPR/Cas9-edited polyclonal knockout cell population in which the DNAJC7 gene has been disrupted in NCI-H1299 cells. This polyclonal pool serves as a heterogeneous loss-of-function model for investigating DNAJC7-dependent proteostasis and stress response mechanisms.

The host NCI-H1299 cell line is a human lung adenocarcinoma line derived from lymph node metastasis. It is TP53 null and grows as an adherent epithelial monolayer, making it a widely used model for p53-independent cancer biology and stress response studies.

DNAJC7 encodes a J-domain co-chaperone that stimulates the ATPase activity of heat shock protein 70 (HSP70) isoforms, primarily HSPA1A and HSPA8. DNAJC7 transcription is induced by heat shock factor 1 (HSF1) in response to proteotoxic stress, and the protein acts by recruiting HSP70 to client polypeptides, where it collaborates with BAG family co-chaperones and the E3 ubiquitin ligase STUB1/CHIP to determine client fate. BAG proteins facilitate nucleotide exchange, while STUB1/CHIP ubiquitinates terminally misfolded clients for proteasomal degradation. Disruption of DNAJC7 disrupts this coordination, impairing HSP70 cycling and leading to accumulation of unfolded client proteins and cytotoxic aggregates. Consequently, cellular proteostasis is compromised, and stress signaling pathways are dysregulated.

In the NCI-H1299 lung adenocarcinoma background, which is TP53 null and therefore deficient in p53-mediated stress responses, DNAJC7 knockout may further sensitize cells to proteotoxic insults, revealing critical dependencies on chaperone-mediated quality control. This model permits investigation of synthetic lethal interactions with proteasome inhibitors (e.g., bortezomib) or HSP90 inhibitors, and the adherent epithelial morphology facilitates high-content imaging of protein aggregation and stress granule dynamics.

Typical applications include investigating chaperone function and proteostasis, western blotting for HSP70 and client proteins, proteasome activity assays, cell viability assays under heat shock or proteasome inhibition, immunofluorescence detection of aggregates, and co-immunoprecipitation of chaperone complexes. The polyclonal knockout population is also suitable for functional genomics screens and drug sensitivity profiling in lung cancer research. For further information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)